
To assess rates and types of genetic diagnoses and clinical outcomes in fetal cardiomyopathy (CM) over two eras to examine the impact of advanced genetic testing and improved perinatal management strategies. We retrospectively reviewed all diagnoses of fetal CM in Alberta, Canada encountered from 2003‐2019. Genetic, cardiac and non‐cardiac diagnoses were documented, as were clinical outcomes. Comparisons were made between the earlier (2003‐2012) and later (2013‐2019) eras. Cases with CM secondary to extracardiac athologies and maternal conditions were excluded...
Like
Save
Share